Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States 2020-03-24 12:24
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States 2020-03-23 19:00
ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai 2020-03-17 23:07
Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate 2020-03-17 08:04
EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells 2020-03-17 00:35
China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government 2020-03-16 21:16
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019 2020-03-13 05:00
NDA Filing for Luye Pharma's Antidepressant Drug LY03005 Accepted by the U.S. FDA 2020-03-04 21:27
China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results 2020-03-03 21:30
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug 2020-03-03 03:00
Yuyu Pharma announces review of compliance policies and procedures 2020-03-02 22:00
China Pharmaceutical Holdings Co., Ltd. Launched A New Product 2020-03-02 20:00
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect 2020-02-27 15:49
WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis 2020-02-27 15:47
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China 2020-02-24 22:00
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321 2020-02-24 08:00
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update 2020-02-21 05:10
StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment 2020-02-20 20:04
111 Partners with Financial Institutions in Battle Against Coronavirus 2020-02-20 17:00
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update 2020-02-19 05:10
1 122 123 124 125 126 165